User:imogenvveh073998

Idacta-mab INT-001 represents the exciting clinical approach for treating certain oncological tumors. The immunoglobulin is a distinct mode of effect, particularly targeting CD-38, a membrane

https://teganyvtb898112.pointblog.net/idactamab-int-001-an-novel-immunoglobulin-in-development-92314082